Marinus Pharmaceuticals I... (MRNS)
0.54
0.00 (0.19%)
At close: Jan 15, 2025, 3:59 PM
0.54
-0.44%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -141.41M | -19.82M | -98.78M | -67.47M | -54.12M | -36.73M | -18.90M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
| Depreciation & Amortization | 551.00K | 418.00K | 355.00K | 334.00K | 278.00K | 127.00K | 126.00K | 23.00K | 11.00K | 5.00K | 9.79K | 17.90K |
| Stock-Based Compensation | 15.56M | 14.89M | 13.87M | 7.64M | 5.67M | 4.79M | 2.88M | 3.08M | 2.11M | 698.00K | 236.37K | 120.60K |
| Other Working Capital | -2.55M | -4.27M | 20.86M | -3.92M | -1.48M | 6.17M | -779.00K | 1.40M | -947.00K | 1.34M | -1.54M | 72.46K |
| Other Non-Cash Items | 5.12M | -102.29M | 1.06M | 626.00K | 94.00K | -79.00K | 4.00K | 7.00K | 7.00K | 4.00K | 90.50K | 305.21K |
| Deferred Income Tax | n/a | n/a | -687.00K | 3.00K | 34.00K | n/a | -28.00K | n/a | 2.00K | -1.19M | -152.69K | -336.05K |
| Change in Working Capital | 2.17M | -6.09M | 28.70M | -2.04M | -590.00K | 4.05M | -2.90M | 767.00K | 2.59M | 2.73M | -1.54M | 72.46K |
| Operating Cash Flow | -118.00M | -112.89M | -55.48M | -60.91M | -48.63M | -27.84M | -18.82M | -24.77M | -20.13M | -8.59M | -6.63M | -1.23M |
| Capital Expenditures | -119.00K | -1.77M | -2.89M | n/a | -388.00K | -83.00K | -450.00K | -644.00K | -352.00K | -33.00K | -17.12K | -5.47K |
| Acquisitions | n/a | 171.00K | n/a | n/a | -4.27M | n/a | n/a | n/a | 352.00K | n/a | n/a | n/a |
| Purchase of Investments | -51.99M | -171.00K | n/a | -8.93M | -2.73M | -24.89M | -24.89M | -2.43M | -7.71M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 23.50M | 107.38M | 1.47M | 8.19M | 6.99M | 20.00M | 3.92M | 4.47M | 1.74M | n/a | n/a | n/a |
| Other Investing Acitivies | 9.00K | 171.00K | 1.47M | -738.00K | 4.27M | 24.89M | -20.97M | 2.04M | -352.00K | n/a | n/a | n/a |
| Investing Cash Flow | -28.61M | 105.77M | -1.42M | -738.00K | 3.88M | 19.92M | -21.42M | 1.40M | -6.31M | -33.00K | -17.12K | -5.47K |
| Debt Repayment | n/a | 58.51M | 40.26M | n/a | n/a | n/a | -5.05M | -2.13M | 28.28M | 6.97M | n/a | 300.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 804.00K | 1.75M | 1.05M | 1.02M | 97.00K | 42.12M | 52.64M | -43.00K | 167.00K | 128.00K | 8.03M | 8.58M |
| Financial Cash Flow | 26.63M | 124.74M | 41.31M | 109.22M | 67.97M | 42.12M | 47.59M | -2.17M | 28.45M | 48.30M | 8.05M | 8.88M |
| Net Cash Flow | -119.98M | 117.62M | -15.58M | 47.57M | 23.22M | 34.20M | 7.35M | -25.54M | 2.00M | 39.68M | 1.40M | 7.65M |
| Free Cash Flow | -118.12M | -114.66M | -58.37M | -60.91M | -49.02M | -27.93M | -19.27M | -25.41M | -20.48M | -8.62M | -6.65M | -1.23M |